Determinants to antiretroviral treatment  non-adherence among adult HIV/AIDS patients  in northern Ethiopia by Abay, Mebrahtu
Gebrezgabher et al. AIDS Res Ther  (2017) 14:16 
DOI 10.1186/s12981-017-0143-1
RESEARCH
Determinants to antiretroviral treatment 
non-adherence among adult HIV/AIDS patients 
in northern Ethiopia
Berhe Beyene Gebrezgabher1, Yigzaw Kebede2, Melaku Kindie2, Desalegn Tetemke1, Mebrahtu Abay1 
and Yalemzewod Assefa Gelaw2*
Abstract 
Background: Adhering 95% and above of antiretroviral therapy reduces the rate of disease progression and death 
among people’s living human immunodeficiency virus. Though manifold factors have reported as determinant fac-
tors of antiretroviral therapy adherence status, perhaps determinants of non-adherence differ up on the activities of 
patients in the study setting.
Methods: An institution based unmatched case–control study was conducted in Aksum town. Individuals who 
had a 6-month follow-up with complete individual information were included in the study. Document review and 
interviewer based techniques were used to collect the data. Binary logistic regression analysis was used to identify the 
determinant factors of non-adherence.
Results: A total of 411 (137 cases and 274 control) study participants were included in the study. The majority of 
them were male in sex. Having 2 years and above duration on ART [AOR = 7, 95% CI (2.2, 22.6)], history of adverse 
effect [AOR = 6.9, 95% CI (1.4, 32.9)], substance use [AOR = 5.3, 95% CI (1.4, 20.0)], living with parents [AOR = 3.4, 95% 
CI (1.2, 10.3)], having depression symptom [AOR = 3.3, 95% CI (1.4, 7.5)], <350 cells/mm3 cluster of differentiation 4 
count [AOR = 3.2, 95% CI (1.8, 5.8)] and low dietary diversity [AOR = 2, 95% CI (1.1, 3.7)] were found significant deter-
minants of non-adherence to antiretroviral drug.
Conclusion: Program, social and individual related factors showed a statistically significant associated with non-
adherence to antiretroviral therapy. Managing lifestyle by developing self-efficacy of individuals and treating related 
threat to improve adherence status of antiretroviral therapy is recommended in this study.
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Background
In 2013 globally, 35 million people living with Human 
Immunodeficiency Virus (HIV). Worthily, sub-Saharan 
Africa (23.5–26.1 million) people living with HIV which 
is 71% of the global prevalence UNAIDS [1]. Ethiopia, an 
estimated 793,700 (716,300–893,200) people living with 
HIV/AIDS [2].
Antiretroviral therapy (ART) is a proven treatment for 
HIV/ADS patients in improving the health status and 
quality of life of HIV/AIDS patients by reducing the rate 
of disease progression [3]. Appropriately taking of the 
treatment is the advisable option in order to obtain full 
benefits of ART; durable suppression of viral replication, 
reduced destruction of CD4 cells, prevention of viral 
resistance, promotion of immune reconstitution, and 
slowed disease progression [4]. Poor ART adherence is 
a notable public health problem in developing countries 
[5].
An individual considered as non-adherence for ART 
if he/she had a history of taking doses 2 or more hours 
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before, and/or 2 or more hours after the time of a doc-
tor’s advice to take doses or missing doses completely 
(i.e., <95% adherence  =  missing  >2 doses of 30 doses 
or >3 doses of 60 doses) [5, 6]. In 2012, over 9.7 million 
people living with HIV in low- and middle-income coun-
tries were receiving ART, however, ensuring adherence to 
HIV treatment remains challenging in all countries [7].
Adherence of ART is a complex behavior, which is 
influenced by several determinants, majorly patient loss 
to follow-up and ensuring adherence to ART regimens 
remain major challenges in Ethiopia [2, 5].
Variables such as; availability of reminder, substance 
use, malnutrition, dietary diversity, CD4 count, depres-
sion symptom, adverse effect of ART and duration on 
ART were reported as a determinant factor for non-
adherence to ART [5, 6, 8–12]. Duration on ART [13, 
14] and CD4 count in [11, 15] were associated with non-
adherence to ART. Determinant factors for non-adher-
ence are multiple and have different effects. This study 
was aimed to identify determinants of non-adherence to 
ART among HIV-infected adults in Aksum town health 
facilities, northern Ethiopia.
Methods
An institution based unmatched case–control study was 
carried out from March 20 to May 15, 2015, in Aksum 
Health Center and Aksum Hospital, Aksum, Ethiopia. 
Aksum town is located 1067 km away in Northeast Ethi-
opia of Addis Ababa, the capital city of Ethiopia.
Sample size and sampling procedure
The sample size of the study was calculated by Epi-Info™ 7 
software Statcalc program using the following assumptions; 
proportion of non-adherence among not exposed (con-
trols) 12.1%, proportion of non-adherence among exposed 
(cases) 21.7%, odds ratio 2.18 [16], 5% level of significance, 
80% power of the study and 1:2 case to control ratio.
All HIV/AIDS positive adults (18+ years old) who had 
at least three consecutive visits before a data collection 
period were considered as a study population of this 
study. The baseline data was collected from two health 
facilities using clinical record review. For the present 
study, study groups based on ART adherence status was 
defined as cases; patients who had a history of greater 5% 
(missing >2 doses out of 30 doses or >3 doses out of 60 
doses) all of scheduled regimens which supposed to take 
in a month and controls were near-perfect (>95%) take to 
dose of all regimens which supposed to take in a month 
[17, 18]. All cases who had to follow-up during the data 
collection period were included in the study whereas 
controls were included by systematic random sampling 
techniques in every other four appointees.
Data collection and data analysis
The data were collected using chart review and inter-
viewer administered techniques by two diploma nurses 
and three case managers working in ART clinics super-
vised by two bachelor nurse professionals. The structured 
questionnaire consisted of socio-demographic, socio-
economic, nutritional, medical and psychological were 
used for the data collection tool. A 1-day training on the 
objective of the study, confidentiality of information and 
interviewing techniques were given. Baseline informa-
tion was filled out from ART registration and follow-up 
forms.
Dietary diversity was assessed by asking the number 
of reported different foods and food groups consumed 
in a household over a 24-h period of the data collection 
time, does not include food group consumed outside the 
home. It was categorized into three groups; low if <3 food 
items consumed, medium if 4–6 food items consumed 
and high if ≥6 food items consumed [19].
Patient Health Questionnaire (PHQ) with 9-items on 
which score ranges from 0 to 27 were used to assess 
the depression of the study participants. Individuals 
up on their response categorized into five categories as 
(no depression, mild depression, moderate depression, 
moderately severe depression and severe depression) 
[20].
Precoding and manual checking of the questionnaire 
were done by the principal investigator before the data 
entry. Data was entered using Epi-Info and exported to 
SPSS version 20 for further cleaning and analysis pur-
pose. Binary logistic regression model used to identify 
the determinant factors. Collinearity diagnostic test 
was conducted using tolerance to check for co-line-
arity between independent variables and interaction 
effect. Variables in the bivariable analysis having a p 
value <0.2 were considered for multivariate analysis to 
adjust the confounders. The strength and presence of 
statistical association were assessed by OR, p value and 
95% confidence interval (95% CI). Variables with a p 
value ≤0.05 were considered as statistically significant 
determinant factors of non-adherence to ART. Hos-
mer–Lemeshow goodness-of-fit test (p  =  0.9289) was 
used to assess the fitness of the model.
Results
A total of 411 HIV-positive individuals (137 cases and 
274 controls) who had at least 6  months ART follow-
up participated in the study. More than half (58.2%) of 
the study participants were male. The mean age ±  (SD) 
at the time of data collection for cases and controls 
were 37.21 (±9.95) and 35 (±8.85) years, respectively 
(Table 1).
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Determinants of non‑adherence to antiretroviral therapy
In multivariable analysis variables, such as duration of 
treatment, ART adverse effect, substance use, living con-
dition, depression, CD4 cell count and dietary diversity 
were found to be independent determinant factors with 
non-adherence to ART.
Patients who had more than 2  years ART follow-up 
[AOR = 7, 95% CI (2.2, 22.6)] were 7 times more likely to 
not adhere as compared to those who had 6–12 months 
follow-up. Patients who had a history of ART adverse 
drug effect [AOR = 6.9, 95% CI (1.4, 32.9)] were 6.9 times 
more likely to be non-adherent as compare to the coun-
terpart. HIV-positive substance user [AOR = 5.3, 95% CI 
(1.4, 20)] individuals who were 5.3 times more likely to be 
non-adherence as compared with the counterpart.
Non-adherence were 3.4 times more likely to occur 
among those who live with their parents [AOR  =  3.4, 
95% CI (1.2, 10.3)] as compared to those who live alone. 
This study also showed that depression is associated with 
non-adherence of ART. The odds of non-adherence were 
3.3 times more likely to those who had depression symp-
tom [AOR = 3.3, 95% CI (1.4, 7.5)] as compared to their 
counterparts.
HIV-positive individuals who had <350 cells/mm3 CD4 
cell count [AOR = 3.2, 95% CI (1.8, 5.8)] were 3.2 times 
more likely to not adhere as compared to those HIV-
positive individuals who had CD4 cell count ≥350 cells/
mm3. Moreover, low dietary diversity [AOR = 2, 95% CI 
(1.1–3.7)] were two times to not adhere as compared to 
the counterparts (Table 2).
Discussion
ART has a proven clinical benefit in HIV-infected people 
by slow downing the progressing to AIDS. Incomplete 
adherence to the treatment leads to immune suppression 
and the selection drug resistant HIV [21]. Non-adher-
ence increases HIV-related morbidity and mortality [22]. 
Numerous studies were conducted on the determinants 
of ART drug-adherence and/or non-adherence of HIV/
AIDS patients in the country. However, studies signify 
the consequence of non-adherence is one or more factors 
that may have different effects consequently; the study 
setting, socio-demographic characteristics of the study 
participants, and sample size. This study showed that 
having 2  years and above duration on ART, depression 
symptoms, history of ART adverse effect, substance use, 
living with parents, <350 cells/mm3 CD4 count and low 
dietary diversity in the household as determinant factors 
for non-adherence to ART.
Coherent with the previous studies in Ethiopia [13, 23] 
HIV-positive participants who had more than 2  years 
ART follow-up were not taken ART drugs appropriately. 
This finding was also coherent with the Asia study con-
ducted in Vientiane, Lao PDR [24]. Findings of Asia [25, 
26] inconsistent with the present study, patients who 
have been on ART for short period were more likely to 
be non-adherent. The possible reason for the discrepancy 
could be these studies were included those patients who 
had less than 6 months’ duration on ART since ART at an 
early phase of treatment may have severed adverse drug 
effects. On top of the treatment duration of the patients, 
the accessibility of health facilities, living conditions, 
socio-demographic characteristics of the population in 
Asia is differ from Ethiopia which might have effect on 
the adherence status of the patient.
Like the report of previous studies conducted in Ethio-
pia [11] and in Nepal [26] in the present study, partici-
pants that had experience of adverse drug effect during 
their medication were more likely to non-adherence to 
ART. But, this study is not consistent with a systematic 
review of Asian developing countries in 2012 reported 
[27]. The possible explanation will be they already 
Table 1 Socio-demographic characteristics at  the time 
of  presentation and  during data collection time of  cases 
and controls, Aksum town, northern Ethiopia 2015
Variables Frequency of adherence status
Case, n (%) Control, n (%)
Sex
 Male 69 (50.4) 170 (62)
 Female 68 (49.6) 104 (38)
Age
 15–29 23 (16.8) 54 (19.7)
 30–39 60 (43.8) 127 (46.4)
 40–49 35 (25.5) 74 (27.0)
 ≥50 19 (13.9) 19 (6.9)
Marital status
 Single 25 (18.2) 47 (17.2)
 Married 64 (46.7) 128 (46.7)
 Widowed 14 (10.2) 32 (11.7)
 Divorced/separated 34 (24.8) 67 (24.4)
Residence
 Urban 114 (83.2) 253 (92.3)
 Rural 23 (16.8) 21 (7.7)
Educational level (grade)
 No formal education 29 (21.2) 57 (20.8)
 Primary education (1–8) 68 (49.6) 128 (46.7)
 Secondary education (9–12) 33 (24.1) 69 (25.2)
 12+ 7 (5.1) 20 (7.3)
Occupation
 No occupation 21 (15.3) 42 (15.3)
 Government employed 25 (18.3) 52 (19)
 Business/self employed 40 (29.2) 96 (35)
 Daily laborer 51 (37.2) 84 (30.7)
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Table 2 Binary and multiple logistic regression model showing determinants of non-adherence to antiretroviral therapy, 
among adults on ART Aksum town, northern Ethiopia 2015
Explanatory variables Adherence status to ART COR (95% CI) AOR (95% CI)
Non‑adherent number (%) Adherent number (%)
Sex
 Male 69 (50.4) 170 (62) 1 1
 Female 68 (49.6) 104 (38) 1.6 (1.1–2.4) 1.4 (0.8–2.4)
Age
 18–29 23 (16.8) 54 (19.7) 1 1
 30–39 60 (43.8) 127 (46.4) 1.1 (0.6–2.0) 1.1 (0.5–2.4)
 40–49 35 (25.5) 74 (27) 1.1 (0.6–2.1) 0.7 (0.3–1.7)
 ≥50 19 (13.9) 19 (6.9) 2.3 (1.1–5.2) 1.7 (0.6–5.0)
Residence
 Urban 114 (83.2) 253 (92.3) 1 1
 Rural 23 (16.8) 21 (76.7) 2.4 (1.3–4.6) 1.4 (0.5–4.0
Occupation
 No occupation 21 (15.3) 42 (15.3) 1 1
 Employed 25 (18.3) 52 (19) 0.9 (0.5–2) 1.4 (0.5–4.2)
 Business 40 (29.2) 96 (35) 0.8 (0.4–1.6) 1.8 (0.7–4.0)
 Farmer 14 (10.2) 10 (3.7) 2.8 (1.1–7.4) 2.3 (0.5–10.3)
 Daily laborer 37 (27) 74 (27) 1 (0.5–1.9) 1.9 (0.8–4.7)
Duration on ART (months)
 6–12 7 (5.1) 38 (13.9) 1 1
 13–24 14 (10.2) 38 (13.9) 2.0 (0.7–5.5) 2 (0.5–8.8)
 ≥25 116 (84.7) 198 (72.2) 3.2 (1.4 7.4) 7 (2.2,22.6)**
ART adverse effect
 Yes 26 (19) 3 (1.1) 21.2 (6.3–71.3) 6.9 (1.4,32.9)**
 No 111 (81) 271 (98.9) 1 1
Substance use
 Yes 21 (15.3) 5 (1.8) 9.7 (3.6–26.5) 5.3 (1.4–20.0)*
 No 116 (84.7) 269 (98.2) 1 1
Live with
 Alone 33 (24.1) 83 (30.3) 1 1
 Parents 18 (13.1) 21 (7.7) 2.2 (1.02–4.6) 3.4 (1.2–10.3)*
 Family 86 (62.8) 170 (62) 1.3 (0.8–2.1) 1.5 (0.8–2.8)
Depression status
 Depressed 41 (29.9) 19 (6.9) 5.7 (3.2–10.4) 3.3 (1.4–7.5)*
 Not depressed 96 (70.1) 255 (93.1) 1 1
CD4 cell count (cells/mm3)
 <350 58 (42.3) 45 (16.4) 3.7 (2.4–6.0) 3.2 (1.8–5.8)*
 ≥350 79 (57.7) 229 (83.6) 1 1
Dietary diversity
 Low 57 (41.6) 43 (15.7) 3.8 (2.4–6.1) 2 (1.1–3.7)*
 Medium and above 80 (58.4) 231 (84.3) 1 1
Daily eating pattern
 ≤2 meals 69 (50.4) 103 (37.6) 1.7 (1.1–2.6) 1.01 (0.6–1.8)
 ≥3 meals 68 (49.6) 171 (62.4) 1 1
Opportunistic infection
 Yes 28 (20.4) 5 (1.8) 13.8 (5.2–36.7) 3.6 (1–13.1)
 No 109 (79.6) 269 (98.2) 1 1
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counselled on the possible side effects of the drug during 
their medication follow-up time.
Substance uses among patients during ART medication 
was also found to be the independent determinant fac-
tors of non-adherence, a finding consistent with a study 
done in southern Ethiopia [16], Tanzania [28] and Nepal 
[26].
In the present study, the living conditions are a deter-
minant factor of non-adherence. Patients living with 
their families were more likely to non-adherence of ART 
drug as compared to those living independent from their 
families, consistent with previous study done in southern 
Ethiopia [29] inconsistent with a study done in Canada 
[30] and Cambodia [31]. The difference may be due to cli-
ents’ self-efficacy and attitude towards ART medication 
is stumpy in the study setting, even at a country level.
The presence of depressive symptoms during medi-
cation is also reported as one of determinant factor for 
ART drug adherence, supported with studies done in 
South-west Ethiopia [14, 29], South Africa [32] and Neth-
erlands [33]. Possibly depressed patients could easily for-
get to take their dose while they managed the depression 
symptoms.
Similar to other studies conducted in Ethiopia [15, 34, 
35], and in Africa [32, 36] the level of CD4 count dur-
ing initiation of treatment have independent effect for 
adherence status. Non-adherence was higher among 
patients with a CD4 count <350 cells/mm3 compared to 
their counterparts. The finding is supported by studies 
in Ethiopia [15, 34, 35] however, a finding reported in 
Yirgalem Hospital, southern Ethiopia [23] was not con-
sistent with the present study. This may be due to the 
previous study controlling for both WHO stages and 
CD4 cell count for the initiation criteria of ART.
Moreover, low dietary habits of the patient are reported 
as the independent determinant factors of non-adher-
ence. This finding is supported by reports in South and 
North Ethiopia [15, 16] and Zambia [37].
Unlike previous studies, socio-demographic factors 
such as sex, age, residence, occupation, eating pattern 
and patient level factors; didn’t show statistically signifi-
cant association with non-adherence of ART. This may be 
because of in this locales the barriers of non-adherence 
were beyond the listed variables.
Since identifications of case and controls were done 
based on the registration log book and individual chart 
review, this paper may be prone to misclassification 
bias. Because of the adherence status of the patient were 
assessed by patient self-report, the non-adherence status 
may underestimate. Moreover, information bias was also 
a problem while assessing dietary diversity, substance use 
and depression symptom.
Conclusion
Having more than 2-year duration on ART follow-up, 
experiencing, adverse ART drug effect, substance use, 
living with parents, having depression symptom, CD4 
cell count <350 cells/mm3 and low dietary diversity 
Table 2 continued
Explanatory variables Adherence status to ART COR (95% CI) AOR (95% CI)
Non‑adherent number (%) Adherent number (%)
Reminder use
 Yes 127 (92.7) 268 (97.8) 0.3 (0.1–0.8) 0.5 (0.–2.0)
 No 10 (7.3) 6 (2.2) 1 1
Stigma
 Yes 17 (12.4) 10 (3.6) 3.7 (1.7–8.4) 2.8 (0.9–8.5)
 No 120 (87.6) 264 (96.4) 1 1
WHO stage
 Stage I 16 (11.7) 68 (24.8) 1 1
 Stage II and above 121 (88.3) 206 (75.2) 2.5 (1.4–4.5) 1.6 (0.8–3.5)
BMI
 Under weight 38 (27.7) 41 (15) 1 1
 Normal 97 (70.8) 224 (81.7) 0.5 (0.3–0.8) 0.7 (0.3–1.3)
 Over weight 2 (1.5) 9 (3.3) 0.2 (0.1–1.2) 0.4 (0.01–3.0)
Treatment other than ART
 Yes 41 (29.9) 40 (14.6) 2.5 (1.5–4.1) 1.4 (0.7–3.0)
 No 96 (70.1) 234 (85.4) 1 1
* p < 0.05
** p < 0.001
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were all found independent determinant factors of non-
adherence of ART drug. Defining the adherence status 
with viral load suppression and/or measured by detect-
able viral load during chronic care and identifying the 
treatment outcome of non-adherence patient is recom-
mended for future researcher.
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